The present invention provides RANKL monoclonal antibodies, particularly humanized monoclonal antibodies specifically binding to RANKL with high affinity. The present invention also provides functional monoclonal antibodies cross-reactive to RANKL of human, cynomolgus monkey and mouse. The present invention further provides amino acid sequences of the antibodies of the invention, cloning or expression vectors, host cells and methods for expressing or isolating the antibodies. The epitopes of the antibodies are identified. Therapeutic compositions comprising the antibodies of the invention are also provided. The invention also provides methods for treating cancers and other diseases with anti-RANKL antibodies.本發明提供了RANKL之單株抗體,特別是高親和力之RANKL人源化單株抗體。本發明還提供與人、食蟹猴及小鼠之RANKL交叉反應之功能性單株抗體。本發明進一步提供了本發明之抗體之胺基酸序列、選殖或表現載體、宿主細胞及用於表現或分離抗體之方法、鑑定抗體之表位。還提供包含本發明抗體之治療組合物。本發明還提供了利用抗RANKL抗體治療癌症及其他疾病之方法。